Corneal Collagen Cross-linking in Advanced Keratoconus: A 4-Year Follow-up Study
Authors:
- Natalia T. GiacominNGNatalia T. Giacomin
- Marcelo V. NettoMNMarcelo V. Netto
- André A. M. TorricelliATAndré A. M. Torricelli
- Gustavo K. MarinoGMGustavo K. Marino
- Samir J. BecharaSBSamir J. Bechara
- Rodrigo F. EspíndolaRERodrigo F. Espíndola
- Marcony R. SanthiagoMSMarcony R. Santhiago
- 1 July 2016
- journal article
- Published by SLACK, Inc. in Journal of Refractive Surgery
- Vol. 32 (7) , 459-465
Abstract
PURPOSE: To analyze the safety and efficacy of standard corneal collagen cross-linking (CXL) in advanced cases of progressive keratoconus after 4 years of follow-up. METHODS: A retrospective case series of patients with advanced progressive keratoconus (stages 3 and 4 of Amsler-Krumeich classification) underwent standard CXL treatment. The parameters examined were changes in uncorrected visual acuity (UDVA), corrected visual acuity (CDVA), keratometry values (mean, flat, steep, and apical), pachymetry, and endothelial cell count at the baseline and at 12, 24, and 48 months postoperatively. RESULTS: Forty eyes of 40 patients were enrolled in the study. The mean patient age was 22.5 years (range: 15 to 37 years). Both mean UDVA and CDVA remained stable during the time points; no statistically significant change was noted. Although a slight reduction was observed in all keratometric readings, a statistically significant reduction was only reached in the apical keratometry ( P = .037) at 4 years after CXL. A significant reduction in the corneal thickness was also found (ultrasonic: 388 ± 49 to 379 ± 48 μ m; slit-scanning: 362 ± 48 to 353 ± 51 μ m); however, this change was likely not clinically meaningful. Endothelial cell count was not significantly different at the end of the study. Treatment failure or progression was noted in two patients (5%) over the follow-up period. CONCLUSIONS: Standard CXL treatment was safe and able to stabilize both visual acuity and topographic parameters at 4 years of follow-up in eyes with advanced keratoconus. [ J Refract Surg. 2016;32(7):459–464.]Keywords
This publication has 29 references indexed in Scilit:
- Corneal Collagen Cross-linking With Riboflavin and Ultraviolet-A Irradiation in Patients With Thin CorneasAmerican Journal of Ophthalmology, 2012
- Patient-Specific Computational Modeling of Keratoconus Progression and Differential Responses to Collagen Cross-linkingInvestigative Ophthalmology & Visual Science, 2011
- Flattening of the cornea after collagen crosslinking for keratoconusJournal of Cataract & Refractive Surgery, 2011
- Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: One-year resultsJournal of Cataract & Refractive Surgery, 2011
- Marked remodelling of the anterior corneal surface following collagen cross-linking with riboflavin and UVABritish Journal of Ophthalmology, 2010
- Long-term Results of Riboflavin Ultraviolet A Corneal Collagen Cross-linking for Keratoconus in Italy: The Siena Eye Cross StudyAmerican Journal of Ophthalmology, 2010
- Scleral Lenses in the Management of KeratoconusEye & Contact Lens: Science & Clinical Practice, 2010
- Effects of Altered Corneal Stiffness on Native and Postoperative LASIK Corneal Biomechanical Behavior: A Whole-eye Finite Element AnalysisJournal of Refractive Surgery, 2009
- Complication and failure rates after corneal crosslinkingJournal of Cataract & Refractive Surgery, 2009
- Stromal haze after combined riboflavin‐UVA corneal collagen cross‐linking in keratoconus: in vivo confocal microscopic evaluationClinical & Experimental Ophthalmology, 2007